4,867
Views
12
CrossRef citations to date
0
Altmetric
Coronaviruses

Sequential infections with rhinovirus and influenza modulate the replicative capacity of SARS-CoV-2 in the upper respiratory tract

ORCID Icon, , ORCID Icon, , , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 413-424 | Received 08 Sep 2021, Accepted 19 Dec 2021, Published online: 27 Jan 2022

References

  • World Health Organization. World health statistics 2016: monitoring health for the SDGs sustainable development goals. Geneva, switzerland: World Health Organization; 2016.
  • Mackie P. The classification of viruses infecting the respiratory tract. Paediatr Respir Rev. 2003;4(2):84–90.
  • Pigny F, Wagner N, Rohr M, et al. Viral co-infections among SARS-CoV-2-infected children and infected adult household contacts. Eur J Pediatr. 2021;80:1991–1995.
  • Singh V, Upadhyay P, Reddy J, et al. SARS-CoV-2 respiratory co-infections: incidence of viral and bacterial co-pathogens. Int J Infect Dis. 2021;105:617–620.
  • Burrel S, Hausfater P, Dres M, et al. Co-infection of SARS-CoV-2 with other respiratory viruses and performance of lower respiratory tract samples for the diagnosis of COVID-19. Int J Infect Dis. 2021;102:10–13.
  • Xiang X, Wang Z, He X, et al. Co-infection of SARS-COV-2 and influenza A virus: a case series and fast review. Wuhan - China: Authorea Preprints; 2020.
  • Alvares PA. SARS-CoV-2 and respiratory syncytial virus coinfection in hospitalized Pediatric patients. Pediatr Infect Dis J. 2021;40(4):e164–e1e6.
  • Adlhoch C, Mook P, Lamb F, et al. Very little influenza in the WHO European region during the 2020/21 season, weeks 40 2020 to 8 2021. Eurosurveillance. 2021;26(11):2100221.
  • Yeoh DK, Foley DA, Minney-Smith CA, et al. The impact of COVID-19 public health measures on detections of influenza and respiratory syncytial virus in children during the 2020 Australian winter. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 2020;72:2199–2202.
  • Gomez GB, Mahé C, Chaves SS. Uncertain effects of the pandemic on respiratory viruses. Science. 2021;372(6546):1043–1044.
  • Mezencev R, Klement C, Dluholucký S. Potential problem of the co-occurrence of pandemic COVID-19 and seasonal influenza. Epidemiologie, Mikrobiologie, Imunologie: Casopis Spolecnosti pro Epidemiologii a Mikrobiologii Ceske Lekarske Spolecnosti JE Purkyne. 2021;70(1):68–71.
  • World Health Organization. Maintaining surveillance of influenza and monitoring SARS-CoV-2: adapting global influenza surveillance and response system (GISRS) and sentinel systems during the COVID-19 pandemic: interim guidance, 8 November 2020. Geneva, Switzerland: World Health Organization; 2020.
  • Davies NG, Abbott S, Barnard RC, et al. Estimated transmissibility and impact of SARS-CoV-2 lineage B. 1.1. 7 in england. Science. 2021;372(6538):1–9.
  • Challen R, Brooks-Pollock E, Read JM, et al. Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study. Br Med J. 2021;372(579):1–10.
  • Lavine JS, Bjornstad ON, Antia R. Immunological characteristics govern the transition of COVID-19 to endemicity. Science. 2021;371(6530):741–745.
  • Essaidi-Laziosi M, Brito F, Benaoudia S, et al. Propagation of respiratory viruses in human airway epithelia reveals persistent virus-specific signatures. J Allergy Clin Immunol. 2018;141(6):2074–2084.
  • Essaidi-Laziosi M, Geiser J, Huang S, et al. Interferon-dependent and respiratory virus-specific interference in dual infections of airway epithelia. Sci Rep. 2020;10(1):1–9.
  • Geiser J, Boivin G, Huang S, et al. RSV and HMPV infections in 3D tissue cultures: mechanisms involved in virus-host and virus-virus interactions. Viruses. 2021;13(1):139.
  • de Lamballerie CN, Pizzorno A, Dubois J, et al. Characterization of cellular transcriptomic signatures induced by different respiratory viruses in human reconstituted airway epithelia. Sci Rep. 2019;9(1):1–12.
  • Pizzorno A, Padey B, Julien T, et al. Characterization and treatment of SARS-CoV-2 in nasal and bronchial human airway epithelia. Cell Reports Med. 2020;1(4):100059.
  • Dee K, Goldfarb DM, Haney J, et al. Human rhinovirus infection blocks SARS-CoV-2 replication within the respiratory epithelium: implications for COVID-19 epidemiology. J Infect Dis. 2021;224(1):31–38.
  • Baggio S, L’Huillier AG, Yerly S, et al. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) viral load in the upper respiratory tract of children and adults With early Acute Coronavirus Disease 2019 (COVID-19). Clin Infect Dis. 2020;73(1):148–150.
  • Felgenhauer U, Schoen A, Gad HH, et al. Inhibition of SARS–CoV-2 by type I and type III interferons. J Biol Chem. 2020;295(41):13958–13964.
  • Vanderheiden A, Ralfs P, Chirkova T, et al. Type I and type III interferons restrict SARS-CoV-2 infection of human airway epithelial cultures. J Virol. 2020;94(19):e00985–20.
  • Xia H, Cao Z, Xie X, et al. Evasion of type I interferon by SARS-CoV-2. Cell Rep. 2020;33(1):108234.
  • DeDiego ML, Nieto-Torres JL, Jimenez-Guardeño JM, et al. Coronavirus virulence genes with main focus on SARS-CoV envelope gene. Virus Res. 2014;194:124–137.
  • Foxman EF, Storer JA, Fitzgerald ME, et al. Temperature-dependent innate defense against the common cold virus limits viral replication at warm temperature in mouse airway cells. Proc Natl Acad Sci USA. 2015;112(3):827–832.
  • Tapparel C, Sobo K, Constant S, et al. Growth and characterization of different human rhinovirus C types in three-dimensional human airway epithelia reconstituted in vitro. Virology. 2013;446(1-2):1–8.
  • V’kovski P, Gultom M, Kelly JN, et al. Disparate temperature-dependent virus–host dynamics for SARS-CoV-2 and SARS-CoV in the human respiratory epithelium. PLoS Biol. 2021;19(3):e3001158.
  • Villenave R, Shields MD, Power UF. Respiratory syncytial virus interaction with human airway epithelium. Trends Microbiol. 2013;21(5):238–244.
  • Hadjadj J, Yatim N, Barnabei L, et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science. 2020;369(6504):718–724.
  • Portela C, Brites C. Immune response in SARS-CoV-2 infection: the role of interferons type I and type III. Braz J Infect Dis. 2020;24(5):428–433.
  • Broggi A, Ghosh S, Sposito B, et al. Type III interferons disrupt the lung epithelial barrier upon viral recognition. Science. 2020;369(6504):706–712.
  • Guo K, Barrett BS, Mickens KL, et al. Interferon resistance of Emerging SARS-CoV-2 variants. bioRxiv. 2021.
  • Bayati A, Kumar R, Francis V, et al. SARS-CoV-2 infects cells after viral entry via clathrin-mediated endocytosis. J Biol Chem. 2021;296:100306.
  • Khan N, Chen X, Geiger JD. Role of endolysosomes in Severe Acute Respiratory Syndrome Coronavirus-2 infection and Coronavirus Disease 2019 pathogenesis: implications for Potential treatments. Front Pharmacol. 2020;11(595888):1–13.
  • Delorme-Axford E, Klionsky DJ. Highlights in the fight against COVID-19: does autophagy play a role in SARS-CoV-2 infection? Rochester and Ann Arbor (USA): Taylor & Francis; 2020.
  • Schweitzer KS, Crue T, Nall JM, et al. Influenza virus infection increases ACE2 expression and shedding in human small airway epithelial cells. Eur Respir J. 2021;58(2003988):1–14.
  • Bai L, Zhao Y, Dong J, et al. Coinfection with influenza A virus enhances SARS-CoV-2 infectivity. Cell Res. 2021;31(4):395–403.